EBV Conference 2008 Guangzhou - Baylor College of Medicine

Monday, November 10
Invited Presentation 5 Monday, November 10
Chairperson: Alison Sinclair 08:15-08:55
08:15-08:55 5 EPTEIN-BARR VIRUS-INDUCED ONCOGENESIS THROUGH
UTILIZING THE INNATE IMMUNITY SYSTEM
Kenzo Takada
Session 9: OTHER MALIGNANCIES AND PTLD 44~46 Monday, November 10
Chairpersons: Shannon Kenney, Lori D Frappier 08:55-09:55
08:55-09:15 44 THE INVESTIGATION OF INTERACTION BETWEEN NASAL
NK/T-CELL LYMPHOMA AND THE INFLAMMATION CELL.
Hideyuki Ishii, Miki Takahara, Yasuaki Harabuchi, Eva Klein
09:15-09:35 45 MECHANISMS UNDERLYING THE SELECTIVE IMPAIRMENT OF
EBNA1-SPECIFIC EFFECTOR T-CELLS OBSERVED IN PTLD.
K. Jones, J. Nourse,S. Yekollu, L. Morrison, D. Moss, MK Gandhi
09:35-09:55 46 CLINICOPATHOLOGIC FEATURES AND EBV GENOME
POLYMORPHISM OF EPSTEIN-BARR VIRUS-ASSOCIATED
GASTRIC CARCINOMA IN GUANGZHOU
Chun-Kui Shao, Jian-Ning Chen, Yun-Gang Ding
09:55-10:10 Morning Coffee
Session 10:IMMUNE MECHANISMS, VACCINE AND IMMUNOTHERAPY Monday, November 10
Chairpersons: Maria Masucci, Jaap Middeldorp 47~53 10:10-12:30
10:10-10:30 47 ACTIVATION AND EXPANSION OF PROTEIN-SPECIFIC T-CELLS BY
UREA FORMULATED PROTEINS OR PEPTIDES: IMPLICATION FOR
DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC APPLICATIONS
Deml, L.; Barabas, S.; Edmaier, K.; Wolf, H.
10:30-10:50 48 EPSTEIN-BARR VIRUS-ENCODED BILF1 CONTRIBUTES TO
IMMUNE EVASION BY TARGETING MHC CLASS I FOR
DEGRADATION
Jianmin ZUO, Andrew CURRIN, Wendy A THOMAS and Martin ROWE
EBV Conference 2008 Guangzhou
- 10 -